{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T06:43:22Z","timestamp":1792392202939,"version":"4.4.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,2,8]],"date-time":"2016-02-08T00:00:00Z","timestamp":1454889600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.ijpddr.2016.02.003","type":"journal-article","created":{"date-parts":[[2016,2,14]],"date-time":"2016-02-14T07:20:57Z","timestamp":1455434457000},"page":"74-84","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Scaffold proteins LACK and TRACK as potential drug targets in kinetoplastid parasites: Development of inhibitors"],"prefix":"10.1016","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2578-1048","authenticated-orcid":false,"given":"Nir","family":"Qvit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Schechtman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darlene Aparecida","family":"Pena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise Aparecida","family":"Berti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chrislaine Oliveira","family":"Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liying (Annie)","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren A.","family":"Baron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Teh-Poot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Mart\u00ednez-Vega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Jesus","family":"Ramirez-Sierra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Churchill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna D.","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrey V.","family":"Malkovskiy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy A.","family":"Federspiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio Cesar","family":"Gozzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Claudia","family":"Torrecilhas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Julia","family":"Manso Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando","family":"Jardim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ndao","family":"Momar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Dumonteil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daria","family":"Mochly-Rosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpddr.2016.02.003_bib1","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.1399-3011.1995.tb01065.x","article-title":"Preparation of the very acid-sensitive Fmoc-Lys(Mtt)-OH. Application in the synthesis of side-chain to side-chain cyclic peptides and oligolysine cores suitable for the solid-phase assembly of MAPs and TASPs","volume":"45","author":"Aletras","year":"1995","journal-title":"Int. J. Pept. Protein Res."},{"key":"10.1016\/j.ijpddr.2016.02.003_bib2","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1550-7408.1982.tb04024.x","article-title":"Adhesion and interiorization of Trypanosoma cruzi in mammalian cells","volume":"29","author":"Andrews","year":"1982","journal-title":"J.\u00a0Protozool."},{"key":"10.1016\/j.ijpddr.2016.02.003_bib3","doi-asserted-by":"crossref","first-page":"5160","DOI":"10.1128\/AAC.49.12.5160-5161.2005","article-title":"A\u00a0cysteine protease inhibitor protects dogs from cardiac damage during infection by Trypanosoma cruzi","volume":"49","author":"Barr","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2016.02.003_bib4","first-page":"886","article-title":"Direct inhibition of delta-protein kinase C enzyme to limit total infarct size in acute myocardial infarction (DELTA MI) investigators","volume":"117","author":"Bates","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.ijpddr.2016.02.003_bib5","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.bbrc.2004.04.121","article-title":"Biodistribution of intracellularly acting peptides conjugated reversibly to TAT","volume":"318","author":"Begley","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ijpddr.2016.02.003_bib6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1051\/parasite\/2014012","article-title":"Chagas disease in the 21st century: a public health success or an emerging threat?","volume":"21","author":"Bonney","year":"2014","journal-title":"Parasite"},{"key":"10.1016\/j.ijpddr.2016.02.003_bib7","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nrmicro1748","article-title":"Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?","volume":"5","author":"Chappuis","year":"2007","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ijpddr.2016.02.003_bib8","doi-asserted-by":"crossref","first-page":"e20710","DOI":"10.1371\/journal.pone.0020710","article-title":"Trypanosomatid RACK1 orthologs show functional differences associated with translation despite similar roles in Leishmania pathogenesis","volume":"6","author":"Choudhury","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ijpddr.2016.02.003_bib9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.tem.2008.10.002","article-title":"Rationally designed peptide regulators of protein kinase C","volume":"20","author":"Churchill","year":"2009","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.ijpddr.2016.02.003_bib10","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/QCO.0000000000000194","article-title":"Leishmaniasis: treatment updates and clinical practice guidelines review","volume":"28","author":"Copeland","year":"2015","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2016.02.003_bib11","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1042\/bj20020386","article-title":"Novel peptide inhibitors of Leishmania gp63 based on the cleavage site of MARCKS (myristoylated alanine-rich C kinase substrate)-related protein","volume":"367","author":"Corradin","year":"2002","journal-title":"Biochem. J."},{"key":"10.1016\/j.ijpddr.2016.02.003_bib12","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.pt.2003.09.008","article-title":"Leishmaniasis-current chemotherapy and recent advances in the search for novel drugs","volume":"19","author":"Croft","year":"2003","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ijpddr.2016.02.003_bib13","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1128\/CMR.19.1.111-126.2006","article-title":"Drug resistance in leishmaniasis","volume":"19","author":"Croft","year":"2006","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ijpddr.2016.02.003_bib14","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1007\/s00726-013-1661-3","article-title":"A\u00a0BODIPY-embedding miltefosine analog linked to cell-penetrating Tat(48-60) peptide favors intracellular delivery and visualization of the antiparasitic drug","volume":"46","author":"de la Torre","year":"2014","journal-title":"Amino Acids"},{"key":"10.1016\/j.ijpddr.2016.02.003_bib15","doi-asserted-by":"crossref","first-page":"30180","DOI":"10.1074\/jbc.M305132200","article-title":"Ankyrin peptide blocks falcipain-2-mediated malaria parasite release from red blood cells","volume":"278","author":"Dhawan","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ijpddr.2016.02.003_bib16","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.drudis.2014.10.003","article-title":"Peptide therapeutics: current status and future directions","volume":"20","author":"Fosgerau","year":"2015","journal-title":"Drug Discov. today"},{"key":"10.1016\/j.ijpddr.2016.02.003_bib17","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1128\/AAC.49.4.1521-1528.2005","article-title":"Treatment with benznidazole during the chronic phase of experimental chagas' disease decreases cardiac alterations","volume":"49","author":"Garcia","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/j.ijpddr.2016.02.003_bib18","first-page":"538","article-title":"Topical treatment for cutaneous leishmaniasis","author":"Garnier","year":"2002","journal-title":"Curr. Opin. investigational drugs (London, England 2000)"},{"key":"10.1016\/j.ijpddr.2016.02.003_bib19","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/bip.360310619","article-title":"Backbone cyclization - a new method for conferring conformational constraint on peptides","volume":"31","author":"Gilon","year":"1991","journal-title":"Biopolymers"},{"key":"10.1016\/j.ijpddr.2016.02.003_bib20","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.exppara.2011.01.008","article-title":"Leishmania mexicana: LACK (Leishmania homolog of receptors for activated C-kinase) is a plasminogen binding protein","volume":"127","author":"Gomez-Arreaza","year":"2011","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.ijpddr.2016.02.003_bib21","doi-asserted-by":"crossref","first-page":"6748","DOI":"10.1073\/pnas.0900226106","article-title":"Leishmania amazonensis promastigotes induce and are killed by neutrophil extracellular traps","volume":"106","author":"Guimaraes-Costa","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijpddr.2016.02.003_bib22","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00726-007-0537-9","article-title":"Targeting the polyamine biosynthetic enzymes: a promising approach to therapy of African sleeping sickness, Chagas' disease, and leishmaniasis","volume":"33","author":"Heby","year":"2007","journal-title":"Amino Acids"},{"key":"10.1016\/j.ijpddr.2016.02.003_bib23","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMra064142","article-title":"Control of neglected tropical diseases","volume":"357","author":"Hotez","year":"2007","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ijpddr.2016.02.003_bib24","doi-asserted-by":"crossref","first-page":"e1498","DOI":"10.1371\/journal.pntd.0001498","article-title":"Chagas disease: \u201cThe new HIV\/AIDS of the americas\u201d","volume":"6","author":"Hotez","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.ijpddr.2016.02.003_bib25","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1161\/01.CIR.0000101682.24138.36","article-title":"Inhibition of delta-protein kinase C protects against reperfusion injury of the ischemic heart in\u00a0vivo","volume":"108","author":"Inagaki","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ijpddr.2016.02.003_bib26","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0003-2697(70)90146-6","article-title":"Color test for detection of free terminal amino groups in solid-phase synthesis of peptides","volume":"34","author":"Kaiser","year":"1970","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ijpddr.2016.02.003_bib27","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1084\/jem.20031162","article-title":"Leishmania major LACK antigen is required for efficient vertebrate parasitization","volume":"198","author":"Kelly","year":"2003","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ijpddr.2016.02.003_bib28","doi-asserted-by":"crossref","first-page":"6831","DOI":"10.1158\/0008-5472.CAN-07-6195","article-title":"Centrosomal PKCbetaII and pericentrin are critical for human prostate cancer growth and angiogenesis","volume":"68","author":"Kim","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijpddr.2016.02.003_bib29","doi-asserted-by":"crossref","first-page":"7414","DOI":"10.1016\/j.vaccine.2010.08.104","article-title":"Effect of a combination DNA vaccine for the prevention and therapy of Trypanosoma cruzi infection in mice: role of CD4+ and CD8+ T cells","volume":"28","author":"Limon-Flores","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.ijpddr.2016.02.003_bib30","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1517\/17425247.2015.1046431","article-title":"Cationic PTD\/CPP-mediated macromolecular delivery: charging into the cell","volume":"12","author":"Lonn","year":"2015","journal-title":"Expert Opin. drug Deliv."},{"key":"10.1016\/j.ijpddr.2016.02.003_bib31","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.1021\/jm021114j","article-title":"Azasterols as inhibitors of sterol 24-methyltransferase in Leishmania species and Trypanosoma cruzi","volume":"46","author":"Magaraci","year":"2003","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ijpddr.2016.02.003_bib32","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1021\/ja0356176","article-title":"Raman spectroscopic characterization of secondary structure in natively unfolded proteins: alpha-synuclein","volume":"126","author":"Maiti","year":"2004","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ijpddr.2016.02.003_bib33","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.cbpa.2006.03.004","article-title":"Mode of action of natural and synthetic drugs against Trypanosoma cruzi and their interaction with the mammalian host","volume":"146","author":"Maya","year":"2007","journal-title":"Comp. Biochem. Physiol. A Mol. Integr. Physiol."},{"key":"10.1016\/j.ijpddr.2016.02.003_bib34","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1124\/mol.62.6.1261","article-title":"The RACK1 scaffold protein: a dynamic cog in cell response mechanisms","volume":"62","author":"McCahill","year":"2002","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ijpddr.2016.02.003_bib35","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1021\/ja00897a025","article-title":"Solid phase peptide synthesis I. The synthesis of a tetrapeptide","volume":"85","author":"Merrifield","year":"1963","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ijpddr.2016.02.003_bib36","first-page":"14","article-title":"Peptide inhibitors of protein-protein interactions","volume":"28","author":"Mochly-Rosen","year":"2010","journal-title":"Chimica Oggi\/CHEMISTRY today"},{"key":"10.1016\/j.ijpddr.2016.02.003_bib37","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/nrd3871","article-title":"Protein kinase C, an elusive therapeutic target?","volume":"11","author":"Mochly-Rosen","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijpddr.2016.02.003_bib38","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1056\/NEJMoa1313122","article-title":"Randomized trial of posaconazole and benznidazole for chronic Chagas' disease","volume":"370","author":"Molina","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ijpddr.2016.02.003_bib39","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1093\/cid\/civ004","article-title":"Miltefosine for visceral and cutaneous leishmaniasis: drug characteristics and evidence-based treatment recommendations","volume":"60","author":"Monge-Maillo","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2016.02.003_bib40","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1517\/17425247.2014.885500","article-title":"Nanoparticles as multifunctional devices for the topical treatment of cutaneous leishmaniasis","volume":"11","author":"Moreno","year":"2014","journal-title":"Expert Opin. drug Deliv."},{"key":"10.1016\/j.ijpddr.2016.02.003_bib41","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1126\/science.7725103","article-title":"Expression cloning of a protective Leishmania antigen","volume":"268","author":"Mougneau","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.ijpddr.2016.02.003_bib42","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.2174\/1389450111009011614","article-title":"Targeting trypanothione metabolism in trypanosomatid human parasites","volume":"11","author":"Olin-Sandoval","year":"2010","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.ijpddr.2016.02.003_bib43","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/psc.849","article-title":"Activity and stability of human kalikrein-2-specific linear and cyclic peptide inhibitors","volume":"13","author":"Pakkala","year":"2007","journal-title":"J.\u00a0Peptide Sci."},{"key":"10.1016\/j.ijpddr.2016.02.003_bib44","doi-asserted-by":"crossref","first-page":"8087","DOI":"10.1021\/jm050819t","article-title":"Antitrypanosomal, antileishmanial, and antimalarial activities of quaternary arylalkylammonium 2-amino-4-chlorophenyl phenyl sulfides, a new class of trypanothione reductase inhibitor, and of N-acyl derivatives of 2-amino-4-chlorophenyl phenyl sulfide","volume":"48","author":"Parveen","year":"2005","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ijpddr.2016.02.003_bib45","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1073\/pnas.85.8.2444","article-title":"Improved tools for biological sequence comparison","volume":"85","author":"Pearson","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijpddr.2016.02.003_bib46","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1016\/j.vaccine.2013.03.005","article-title":"Preventive and therapeutic DNA vaccination partially protect dogs against an infectious challenge with Trypanosoma cruzi","volume":"31","author":"Quijano-Hernandez","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.ijpddr.2016.02.003_bib47","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1021\/cc700113c","article-title":"Synthesis of a novel macrocyclic library: discovery of an IGF-1R inhibitor","volume":"10","author":"Qvit","year":"2008","journal-title":"J.\u00a0Comb. Chem."},{"key":"10.1016\/j.ijpddr.2016.02.003_bib48","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1016\/j.ddmec.2010.07.001","article-title":"Highly specific modulators of protein kinase C localization: applications to heart failure","volume":"7","author":"Qvit","year":"2010","journal-title":"Drug Discov. Today Dis. Mech."},{"key":"10.1016\/j.ijpddr.2016.02.003_bib49","first-page":"4","article-title":"Development and therapeutic applications of oligonucleotides and peptides","volume":"29","author":"Qvit","year":"2011","journal-title":"Chimica Oggi\/CHEMISTRY today"},{"key":"10.1016\/j.ijpddr.2016.02.003_bib50","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/cbdd.12388","article-title":"Microwave-assisted synthesis of cyclic phosphopeptide on solid support","volume":"85","author":"Qvit","year":"2014","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ijpddr.2016.02.003_bib51","first-page":"62","article-title":"Peptides that target protein-protein interactions as an anti-parasite strategy","volume":"32","author":"Qvit","year":"2014","journal-title":"Chimica Oggi\/CHEMISTRY today"},{"key":"10.1016\/j.ijpddr.2016.02.003_bib52","series-title":"Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation","first-page":"e53589","author":"Qvit","year":"2016"},{"key":"10.1016\/j.ijpddr.2016.02.003_bib53","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nchembio837","article-title":"Drug discovery and development for neglected parasitic diseases","volume":"2","author":"Renslo","year":"2006","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ijpddr.2016.02.003_bib54","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.drudis.2014.09.017","article-title":"Therapeutic applications of the cell-penetrating HIV-1 Tat peptide","volume":"20","author":"Rizzuti","year":"2015","journal-title":"Drug Discov. today"},{"key":"10.1016\/j.ijpddr.2016.02.003_bib55","doi-asserted-by":"crossref","first-page":"9781","DOI":"10.1074\/jbc.M600133200","article-title":"The RACK1 homologue from Trypanosoma brucei is required for the onset and progression of cytokinesis","volume":"281","author":"Rothberg","year":"2006","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ijpddr.2016.02.003_bib56","doi-asserted-by":"crossref","first-page":"6339","DOI":"10.1038\/sj.onc.1204778","article-title":"Adaptor proteins in protein kinase C-mediated signal transduction","volume":"20","author":"Schechtman","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.ijpddr.2016.02.003_bib57","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.4155\/fmc.11.77","article-title":"Phosphodiesterase inhibitors as a new generation of antiprotozoan drugs: exploiting the benefit of enzymes that are highly conserved between host and parasite","volume":"3","author":"Seebeck","year":"2011","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ijpddr.2016.02.003_bib58","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1128\/AAC.01796-10","article-title":"Selective inhibitors of methionyl-tRNA synthetase have potent activity against Trypanosoma brucei Infection in Mice","volume":"55","author":"Shibata","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2016.02.003_bib59","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1101\/gr.772403","article-title":"PANTHER: a library of protein families and subfamilies indexed by function","volume":"13","author":"Thomas","year":"2003","journal-title":"Genome Res."},{"key":"10.1016\/j.ijpddr.2016.02.003_bib60","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ijpddr.2013.11.002","article-title":"Untargeted metabolomic analysis of miltefosine action in Leishmania infantum reveals changes to the internal lipid metabolism","volume":"4","author":"Vincent","year":"2014","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"10.1016\/j.ijpddr.2016.02.003_bib61","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1586\/14787210.7.2.157","article-title":"Side effects of benznidazole as treatment in chronic Chagas disease: fears and realities","volume":"7","author":"Viotti","year":"2009","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"10.1016\/j.ijpddr.2016.02.003_bib62","first-page":"68","article-title":"In\u00a0vitro sensitivity of Leishmania (Viannia) braziliensis and Leishmania (Leishmania) amazonensis Brazilian isolates to meglumine antimoniate and amphotericin B","volume":"15","author":"Zauli-Nascimento","year":"2010","journal-title":"Trop. Med. Int. Health"}],"container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320716300100?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320716300100?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:45:30Z","timestamp":1761921930000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211320716300100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S2211320716300100"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpddr.2016.02.003","relation":{},"ISSN":["2211-3207"],"issn-type":[{"value":"2211-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Scaffold proteins LACK and TRACK as potential drug targets in kinetoplastid parasites: Development of inhibitors","name":"articletitle","label":"Article Title"},{"value":"International Journal for Parasitology: Drugs and Drug Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpddr.2016.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}